In light of the rapidity increasing incidence rate of bacterial and fungal infections with multi-resistant pathogens, the metabolic changes associated with host-pathogen interactions offer one of the most promising starting points for developing novel antibiotics. . Part one of this comprehensive guide describes the metabolic adaptation of pathogenic microbes in humans, while part two points to routes for the development of novel antibiotics. This is volume six of the book series on drug discovery in infectious diseases by Paul Selzer.
PART 1: ADAPTATION OF MICROBIAL METABOLISM IN HOST/PATHOGEN INTERACTION Metabolic adaptation of human pathogenic yersiniae Crosstalk between metabolism and virulence of Legionella pneumophila Metabolism of intracellular Salmonella enterica The human microbiome in health and disease Mechanisms of dysbiosis in the inflamed gut Strategies for microbial nutrient acquisition during infection of rice by Magnaporthe oryzae PART 2: NEW INHIBITORS AND TARGETS OF INFECTIOUS DISEASES Outer membrane proteins as potential anti-infective drug targets in Mannheimia haemolytica Identification of anti-infective compounds using amoebae Stress biology in fungi and "omic"-approaches as suitable tools analyzing plant-microbe interactions Targeting plasmids: new ways to plasmid curing Regulation of secondary metabolism in the grey mould fungus Botrytis cinerea
Gottfried Unden studied Biology and Chemistry at the Ludwig Maximilians University Munich where he received his Dr. rer. nat. Since 1993 he is Professor for Microbiology at the Department of Microbiology and Wine Research at the University of Mainz. The main areas of work is bacterial metabolism and its adaptation to changing environmental conditions like switching from aerobic to anaerobic metabolism, or the use of carboxylic acid as the substrate for growth, and the function of bacterial sensors.
Eckhard Thines studied Biology at the University of Kaiserslautern, Germany, where he received his PhD in Biotechnology. As a postdoctoral fellow he spent two years in Professor Nicholas Talbot's laboratory in Exeter, UK. He joined the Institute of Biotechnology and Drug Research (IBWF) in Kaiserslautern, Germany in 2006. Since 2009 he is CSO of the IBWF and since 2012 he is Professor for Biotechnology and Drug Research at the University of Mainz. His research focusses on fungicide research, mode of action research, target identification and validation as well as fungal secondary metabolism. Furthermore he is interested in host/pathogen-interactions in fungal plant diseases, e.g. Esca and grape black rot.
Anja Schüffler studied Biology at the University of Kaiserslautern. Her PhD focused on the characterisation of fungal natural products with antimicrobial activity. In 2010 she joined Professor William Fenical´s group at the Scripps Institute for Oceanography in San Diego, where she studied antibacterial natural products fromstreptomycetes. In 2011 she started a research fellowship at the Institute of Biotechnology and Drug Research (IBWF, Kaiserslautern). Her scientific work focuses on fungal bioactive natural products and assay development, the biosynthesis of secondary metabolites, as well as isolation and taxonomy of fungi.
Paul M. Selzer studied biology, parasitology, and biochemistry at the University of Tübingen, Germany, where he also received his PhD in biochemistry. He spent three years at the Molecular Design Institute and the Parasitology and Tropical Disease Research Laboratory at the University of California, San Francisco. During his career he has worked as a researcher and scientific manager for several pharmaceutical companies, and is currently Director, Molecular Discovery Sciences at MSD Animal Health Innovation GmbH, Germany. He is also a visiting professor and teacher at the Biochemistry Institute of the University of Tübingen, and an honorary professor of the Department of Infection, Immunity, and Inflammation at the University of Glasgow, UK.